Reported Earlier, Arcus Biosciences Prices 14,285,715 Common Shares Public Offering At $17.50 Per Share, Targets $250M In Gross Proceeds

Loading news article.

Reported Earlier, Arcus Biosciences Prices 14,285,715 Common Shares Public Offering At $17.50 Per Share, Targets $250M In Gross Proceeds | WAPE

Article summary